http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10500216-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fcbc9ca53bc68f405f71764197469b5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
filingDate 2012-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_269d453d6fac53cc1860df70cdea5035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92984c3d9fb5a254e519444cbe18a1a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23baa87ed06a7fa2e6288fee84779b7e
publicationDate 2019-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-10500216-B2
titleOfInvention Optimizing mifepristone absorption
abstract The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11173165-B2
priorityDate 2011-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009050136-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7326697-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6369046-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7361646-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007238779-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8598149-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006063748-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004229855-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011294771-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7163934-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6964953-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011144072-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8921348-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6680310-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010261693-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016310507-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7402578-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6620802-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6150349-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8097606-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010179115-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011166115-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004132703-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507520

Total number of triples: 42.